Title |
Chapter 6 – Prodrug design for improving the biopharmaceutical properties of therapeutic drugs |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00006-2 |
Page No |
179-226 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 7 – Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00007-4 |
Page No |
227-258 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 8 – Mass spectrometry imaging in lipid and proteomic profiling: an emerging tool for cancer diagnosis |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00008-6 |
Page No |
259-295 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 9 – Photothermal therapy as emerging combinatorial therapeutic approach |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00009-8 |
Page No |
297-339 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 10 – Small interfering RNA-based advanced nanoparticles for the treatment of cancer |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00010-4 |
Page No |
341-365 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 11 – Recent advances in regenerative medicine |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00011-6 |
Page No |
367-412 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 12 – Pharmacogenomics and pharmacoepigenomics: Impact on therapeutic strategies |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00012-8 |
Page No |
413-446 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 13 – Recombinant blood products and therapeutic enzymes: An update |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00013-X |
Page No |
447-482 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 14 – New advances in insulin products |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00014-1 |
Page No |
483-514 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|
Title |
Chapter 15 – Gene delivery to tackle diabetic nephropathy |
Faculty Authors |
Dr. Rakesh Kumar Tekade |
Impact Factor |
N.A |
Year |
2020 |
DOI Number |
doi.org/10.1016/B978-0-12-814455-8.00015-3 |
Page No |
515-537 |
Volume No |
|
Department |
Department of Pharmaceutics |
Paper Type |
Book Chapter Paper |
Issue No |
|
Journal Name |
Nil |
|